Evidence map›Paper›PMID 38453930›Full record

ArticleNPJ primary care respiratory medicine2024

Medication adherence halves COPD patients' hospitalization risk - evidence from Swiss health insurance data.

Anja Y Bischof, Johannes Cordier, Justus Vogel, Alexander Geissler

Open access · goldAbstract read
In one paragraph

Article in NPJ primary care respiratory medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Medication adherence in patients with nontuberculous mycobacterial disease.Journal of clinical tuberculosis and other mycobacterial diseases · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Anja Y BischofSchool of Medicine, University of St. Gallen, St. Gallen, Switzerland. anja.bischof@unisg.ch.ORCID 0000-0002-9318-5408
Johannes CordierSchool of Medicine, University of St. Gallen, St. Gallen, Switzerland.ORCID 0009-0002-0083-5182
Justus VogelSchool of Medicine, University of St. Gallen, St. Gallen, Switzerland.ORCID 0000-0002-2605-8994
Alexander GeisslerSchool of Medicine, University of St. Gallen, St. Gallen, Switzerland.
University of St.Gallen · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Medication adherence is vital for patients suffering from Chronic Obstructive Pulmonary Disease (COPD) to mitigate long-term consequences. The impact of poor medication adherence on inferior outcomes like exacerbations leading to hospital admissions is yet to be studied using real-world data. Using Swiss claims data from 2015-2020, we group patients into five categories according to their medication possession ratio. By employing a logistic regression, we quantify each category's average treatment effect of the medication possession ratio on hospitalized exacerbations. 13,557 COPD patients are included in the analysis. Patients with high medication adherence (daily medication reserve of 80% to 100%) are 51% less likely to incur exacerbation following a hospital stay than patients with the lowest medication adherence (daily medication reserve of 0% to 20%). The study shows that medication adherence varies strongly among Swiss COPD patients. Furthermore, high medication adherence immensely decreases the risk of hospitalized exacerbations.

Indexed as

Pulmonary Disease, Chronic ObstructiveDisease ProgressionHospitalizationHumansInsurance, HealthMedication AdherenceRetrospective StudiesSwitzerland

Identifiers

PMID38453930
PMCPMC10920735
OpenAlexW4392545029

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.